I now have rich content from Lippincott's, Basic Medical Biochemistry, and other top sources. Let me now produce the complete, exam-oriented study notes with mnemonics in Hindi context.
🔥 BIOCHEMISTRY COMPETITION EXAM NOTES
One-Day High-Yield Master Study Guide
Special Focus: ⭐⭐⭐⭐⭐ Priority Topics
⭐⭐⭐⭐⭐ TOPIC 1: REGULATION OF BLOOD GLUCOSE LEVELS
KEY CONCEPT (Score Line: "The Liver is the Glucose Bank of the Body")
Mnemonic (Hindi): "MANIK ne GLUCOSE BANK khola" - Manik = Maintains glucose; Glycogen synthesis, Lysis, Urea, Conjugation, Overall homeostasis via pancreas, Sensitivity of liver to insulin
Normal Blood Glucose Range
- Fasting: 70-100 mg/dL (3.9-5.6 mmol/L)
- Postprandial (2h): < 140 mg/dL
- Hypoglycemia: < 70 mg/dL
- Hyperglycemia (DM): > 126 mg/dL fasting
FLOWCHART: Blood Glucose Regulation
BLOOD GLUCOSE RISES (fed state)
|
Pancreatic β-cells
|
↑ INSULIN secretion
|
┌────────────────────────┐
│ Insulin Actions │
│ • ↑ Glycogen synthesis │
│ • ↑ Glycolysis │
│ • ↑ Fatty acid synth │
│ • ↑ Protein synthesis │
│ • ↓ Gluconeogenesis │
│ • ↓ Glycogenolysis │
└────────────────────────┘
|
Glucose stored as glycogen/fat
Blood glucose → NORMAL
═══════════════════════════════
BLOOD GLUCOSE FALLS (fasting)
|
Pancreatic α-cells
|
↑ GLUCAGON secretion
+ ↑ Cortisol, Epinephrine, GH (counter-regulatory)
|
┌────────────────────────┐
│ Glucagon Actions │
│ • ↑ Glycogenolysis │
│ • ↑ Gluconeogenesis │
│ • ↑ Fatty acid oxidation│
│ • ↓ Glycogen synthesis │
│ • ↓ Glycolysis │
└────────────────────────┘
|
Glucose released into blood
Blood glucose → NORMAL
KEY ENZYMES REGULATED (Exam Favorite!)
| Pathway | Key Enzyme | Activated by | Inhibited by |
|---|
| Glycolysis | PFK-1 | AMP, F-2,6-BP, Insulin | ATP, Citrate, Glucagon |
| Gluconeogenesis | F-1,6-BPase | Glucagon, cAMP | F-2,6-BP, AMP |
| Glycogen synthesis | Glycogen synthase | Insulin, Glucose-6-P | Glucagon, Epinephrine |
| Glycogenolysis | Glycogen phosphorylase | Glucagon, Epinephrine | Insulin, Glucose |
| FA synthesis | Acetyl-CoA carboxylase | Insulin, Citrate | Glucagon, Malonyl-CoA |
Mnemonic: "RISHIKA PICKS FATS ALWAYS" for Insulin actions:
- R - aReinforces glycogen synthesis
- I - Increases glycolysis
- S - Stimulates protein synthesis
- H - HMP shunt increases
- I - Inhibits gluconeogenesis
- K - Ketogenesis is suppressed
- A - Activates FA synthesis
KEY KINASES (Two Master Switches)
- cAMP-dependent Protein Kinase A (PKA) - activated by glucagon/epinephrine → phosphorylates enzymes → activates glycogenolysis, gluconeogenesis
- AMP-activated Protein Kinase (AMPK) - activated when energy is low (↑AMP) → stimulates FA oxidation, inhibits FA synthesis
Memory trick: "PKA = Paisa Kam Ata (cAMP ke baad)" = When glucagon signals (low glucose) → PKA activated
LIVER'S UNIQUE ROLE
- Glucose-6-phosphatase present ONLY in liver and kidney → can export free glucose to blood
- Liver = "glucose thermostat" of body
- Glucose transporter GLUT-2 in liver - high Km, not saturated → acts as glucose sensor
COUNTER-REGULATORY HORMONES (SHEG Mnemonic):
- S - Somatostatin (inhibits both insulin & glucagon)
- H - HGH (Growth Hormone) - insulin antagonist
- E - Epinephrine - activates glycogenolysis
- G - Glucocorticoids (Cortisol) - promotes gluconeogenesis
Hindi Mnemonic: "SHUBHAM had SHEG" = Shubham lost glucose control, needed SHEG hormones to rescue!
⭐⭐⭐⭐⭐ TOPIC 2: BETA OXIDATION OF FATTY ACIDS & DISORDERS
KEY CONCEPT: "CAFE → Energy"
(Carnitine shuttle → Activation → FAD/NAD reactions → Energy from Acetyl-CoA)
FLOWCHART: Beta Oxidation
FATTY ACID (cytoplasm)
|
Fatty acyl-CoA synthetase (+ ATP, CoA)
|
Fatty acyl-CoA (outer mitochondrial membrane)
|
CPT-I (Carnitine Palmitoyl Transferase-I)
[RATE-LIMITING STEP]
Inhibited by: MALONYL-CoA
|
Fatty acyl-CARNITINE crosses inner membrane
(via Carnitine-acylcarnitine TRANSLOCASE)
|
CPT-II releases fatty acyl-CoA inside
|
═══ INSIDE MITOCHONDRIA ═══
|
STEP 1: Acyl-CoA Dehydrogenase
→ Trans-enoyl-CoA + FADH₂
|
STEP 2: Enoyl-CoA Hydratase
→ 3-L-Hydroxyacyl-CoA
|
STEP 3: 3-Hydroxyacyl-CoA Dehydrogenase
→ 3-Ketoacyl-CoA + NADH
|
STEP 4: Thiolase (cleavage)
→ Acetyl-CoA + shorter Fatty acyl-CoA
|
(Cycle repeats with shorter chain)
|
Final product: All ACETYL-CoA
|
↓
TCA Cycle → ATP synthesis
OR
Ketone body synthesis (in liver)
ATP YIELD (Palmitic acid C16:0 - Exam Favorite!)
Formula: For C16 fatty acid = 7 cycles of beta oxidation
| Product per cycle | Total (x7 cycles) | ATP equivalent |
|---|
| 7 FADH₂ | 7 × 1.5 = | 10.5 ATP |
| 7 NADH | 7 × 2.5 = | 17.5 ATP |
| 8 Acetyl-CoA | 8 × 10 = | 80 ATP |
| Activation (−2 ATP) | | −2 ATP |
| TOTAL | | = 106 ATP |
Mnemonic: "DIVYA earns 106" - Divya studied hard for 7 rounds, earned 106 marks!
PEROXISOMAL vs MITOCHONDRIAL Beta Oxidation
| Feature | Mitochondrial | Peroxisomal |
|---|
| Chain length | Short/Medium/Long | Very long chain (>C22) |
| Carnitine needed | YES (CPT-I, II) | NO |
| First step cofactor | FAD → FADH₂ → ETC | FAD → FADH₂ → H₂O₂ |
| ATP produced | YES (efficient) | Less (H₂O₂ produced) |
| Completes oxidation | Yes (to CO₂+H₂O) | Only to octanoyl-CoA, then mitochondria |
KEY DISORDERS OF BETA OXIDATION
1. Refsum Disease
- Defect: Phytanoyl-CoA hydroxylase deficiency
- Problem: Cannot oxidize phytanic acid (branched chain FA from green vegetables/dairy)
- Accumulates: Phytanic acid (3-methyl branched)
- Clinical: Retinitis pigmentosa, peripheral neuropathy, cerebellar ataxia, anosmia, deafness
- Mnemonic: "RADHIKA smells nothing, sees nothing" - Radhika = Refsum, anosmia + retinitis pigmentosa
2. Zellweger Syndrome (Cerebrohepatorenal Syndrome)
- Defect: Absent/dysfunctional peroxisomes (PEX gene mutations)
- Problem: Cannot import proteins into peroxisomes
- Clinical: Facial dysmorphism, hypotonia, seizures, liver dysfunction, death in infancy
- Key finding: Very long chain fatty acids (VLCFA) accumulate in blood
- Mnemonic: "SHUBHAM has no PEROXY" - Shubham's peroxisomes are gone → Zellweger
3. MCAD Deficiency (Medium-Chain Acyl-CoA Dehydrogenase)
- Defect: Cannot oxidize C6-C12 fatty acids
- Clinical: Hypoketotic hypoglycemia during fasting, vomiting, lethargy → sudden death
- = Jamaican Vomiting Sickness (similar mechanism)
- Jamaican Vomiting Sickness: Due to hypoglycin A in unripe ackee fruit → inhibits MCAD
- Mnemonic: "NAMANYA vomited from Jamaica" - Namanya = No MCAD = vomiting
4. Sudden Infant Death Syndrome (SIDS)
- Associated with MCAD deficiency or other FA oxidation defects
- Infant cannot maintain blood glucose during prolonged fasting (overnight)
- Hypoketotic hypoglycemia → cardiac arrest
⭐⭐⭐⭐⭐ TOPIC 3: AMMONIA METABOLISM & UREA CYCLE
KEY CONCEPT: "Liver is the Ammonia Garbage Collector"
NH₃ is toxic to CNS even at slightly elevated levels → must be converted to UREA (non-toxic, water-soluble, excreted in urine)
SOURCES OF AMMONIA (Mnemonic: "MANIK gives NH3")
- M - Muscle protein catabolism (BCAA → glutamine)
- A - Amino acid transdeamination in liver
- N - kNot bacteria (intestinal bacteria via urease on urea)
- I - Intestinal glutaminase (major source!)
- K - Kidney (glutamine → NH₄⁺ for acid-base balance)
Additional sources:
- Amines → MAO (monoamine oxidase) → NH₃
- Purines/Pyrimidines catabolism
TRANSPORT OF AMMONIA TO LIVER (Key!)
Two main carriers:
1. GLUTAMINE (most important in blood transport)
Glutamate + NH₃ → [Glutamine synthetase] → GLUTAMINE
(All peripheral tissues, especially muscle, brain)
↓ (to liver)
Glutamine → [Glutaminase] → Glutamate + NH₃
(then NH₃ enters urea cycle)
2. ALANINE-GLUCOSE CYCLE (from muscle)
Muscle: Pyruvate + Glutamate → [Transamination] → ALANINE
↓
(Alanine travels to liver)
↓
Liver: Alanine + α-KG → Pyruvate + Glutamate → NH₃
↓
Pyruvate → Gluconeogenesis → GLUCOSE (sent back to muscle)
Mnemonic: "RADHIKA carries her amino lunch to LIVER" = Radhika (ALANINE) cycles from muscle to liver
FLOWCHART: UREA CYCLE (Diagrammatic)
╔══════════ MITOCHONDRIA ══════════╗
║ ║
║ NH₃ + CO₂ + 2ATP ║
║ ↓ ║
║ CPS-I (N-acetylglutamate) ║
║ (Carbamoyl Phosphate Synthetase-I)║
║ ↓ ║
║ CARBAMOYL PHOSPHATE ║
║ ↓ ║
║ OTC (Ornithine Transcarbamylase) ║
║ ORNITHINE → CITRULLINE ║
║ ║
╚═══════════════════════════════════╝
↓ (Citrulline exits to cytoplasm)
╔══════════ CYTOPLASM ══════════════╗
║ ║
║ CITRULLINE + ASPARTATE + ATP ║
║ ↓ ║
║ Argininosuccinate SYNTHETASE ║
║ ↓ ║
║ ARGININOSUCCINATE ║
║ ↓ ║
║ Argininosuccinate LYASE ║
║ ↓ ║
║ ARGININE + FUMARATE ║
║ ↓ ║
║ ARGINASE (liver only!) ║
║ ↓ ║
║ UREA + ORNITHINE ║
║ (Ornithine returns to mito) ║
║ (Urea → kidney → excreted) ║
║ ║
╚═══════════════════════════════════╝
MNEMONIC for Urea Cycle Steps: "DIVYA CALLS ORNITHINE CITRULLINE ARGININE UREA"
Or simpler: "OCO CAL AFAR"
- Ornithine + Carbamoyl-P → Citrulline (OTC, in MITO)
- Citrulline + Aspartate → Argininosuccinate
- Argininosuccinate → Arginine + Fumarate
- Arginine → Urea + Ornithine (ARGINASE)
ENERGY COST OF UREA CYCLE
- 4 ATP equivalents consumed per urea molecule
- 2 ATP → CPS-I step
- 1 ATP (as AMP = 2 high-energy bonds) → argininosuccinate synthetase step
ALLOSTERIC REGULATION
- CPS-I activated by: N-ACETYLGLUTAMATE (NAG) - obligatory activator
- NAG is synthesized by NAG synthetase from acetyl-CoA + glutamate
- Arginine stimulates NAG synthetase (positive feedback)
- When protein intake increases: more arginine → more NAG → more CPS-I activity → more urea synthesis
HYPERAMMONEMIA - Causes & Features
| Type | Defect | Key Finding |
|---|
| Type I | CPS-I deficiency | No orotic acid |
| Type II (OTC deficiency) | OTC (X-linked!) | ↑ OROTIC ACID |
| Citrullinemia | Argininosuccinate synthetase | ↑ Citrulline |
| Argininosuccinic aciduria | Argininosuccinate lyase | ↑ Argininosuccinate |
| Arginase deficiency | Arginase | ↑ Arginine, SPASTIC DIPLEGIA |
| Acquired (liver disease) | Multiple | ↑ NH₃, ↑ Glutamine |
KEY DIFFERENTIATOR:
OTC deficiency (most common UCD):
- X-linked recessive (boys affected, girls carriers)
- ↑ Orotic acid (carbamyl phosphate shunted to pyrimidine synthesis)
- Treatment: Low protein diet, sodium benzoate (binds glycine → hippurate), sodium phenylacetate (binds glutamine)
CPS-I deficiency:
- Autosomal recessive
- NO orotic acid (CPS-II not affected)
- Requires N-acetylglutamate for treatment
Mnemonic: "MANIK has OTC X-problem" - OTC = X-linked, Male affected
CLINICAL SIGNS OF HYPERAMMONEMIA
- Lethargy, irritability
- Vomiting
- Respiratory alkalosis (early - NH₃ stimulates respiratory center)
- Cerebral edema → coma → death
- ↑ Glutamine in CSF (NH₃ + Glutamate → Glutamine, depletes α-KG → TCA cycle disrupted)
KETONE BODY METABOLISM (⭐ Bonus - Most Repeated!)
KEY CONCEPT: "Liver makes ketones, but CANNOT use them"
SYNTHESIS (in LIVER mitochondria only)
Acetyl-CoA + Acetyl-CoA
↓ [Thiolase]
Acetoacetyl-CoA
↓ [HMG-CoA synthase] ← RATE-LIMITING STEP
HMG-CoA
↓ [HMG-CoA lyase]
ACETOACETATE + Acetyl-CoA
↓ ↓
[β-HB dehydrogenase] Spontaneous decarboxylation
β-HYDROXYBUTYRATE ACETONE (excreted in breath)
Mnemonic: "SHUBHAM MAKES HMG" = Shubham (liver) Makes HMG-CoA → ketones for others
UTILIZATION (in all tissues EXCEPT LIVER)
β-Hydroxybutyrate → [β-HB dehydrogenase] → Acetoacetate
↓
[Succinyl-CoA transferase (SCOT)] ← ABSENT IN LIVER!
↓
Acetoacetyl-CoA → 2 Acetyl-CoA → TCA cycle
WHY LIVER CANNOT USE KETONE BODIES?
SCOT (Succinyl-CoA: Acetoacetate CoA-Transferase) is absent in hepatocytes
KETOSIS vs KETOACIDOSIS
| Starvation Ketosis | Diabetic Ketoacidosis |
|---|
| Cause | Prolonged fasting | Insulin deficiency (Type 1 DM) |
| Blood glucose | Normal/low | HIGH (>250 mg/dL) |
| Ketone bodies | Mildly elevated | Severely elevated |
| pH | Normal or mild acidosis | < 7.3 |
| Anion gap | Mildly elevated | HIGH |
| Response to glucose | Resolves | Needs insulin |
Mnemonic "NAMANYA DKA rule": DKA = Diabetes + Ketones + Acidosis (pH < 7.3, Bicarbonate < 15, Glucose > 250)
QUICK REFERENCE: OTHER KEY TOPICS
FLUID MOSAIC MODEL (Singer-Nicolson 1972)
- Membrane = phospholipid bilayer (fluid) + proteins (mosaic pattern)
- Lipids can move laterally (fast) but flip-flop (slow/rare)
- Proteins: Integral (span membrane) and Peripheral (surface attached)
- Cholesterol = membrane stabilizer (regulates fluidity)
TRANSPORT ACROSS CELL MEMBRANE
| Type | Energy | Carrier | Direction | Example |
|---|
| Simple diffusion | No | No | Conc gradient | O₂, CO₂, steroids |
| Facilitated diffusion | No | Yes | Conc gradient | Glucose (GLUT), Fructose |
| Active transport (Primary) | Yes (ATP) | Yes | Against gradient | Na⁺/K⁺-ATPase |
| Active transport (Secondary) | Indirect | Yes | Against gradient | Na⁺-Glucose cotransport (SGLT) |
| Endocytosis/Exocytosis | Yes | No | - | LDL receptor, insulin |
Mnemonic: "DIVYA SAFI" - Simple, Active, Facilitated, Endo/exocytosis
ENZYME CLASSIFICATION (EC Numbers - "OTH LI")
- Oxidoreductases - redox reactions (dehydrogenases, oxidases)
- Transferases - transfer groups (aminotransferases, kinases)
- Hydrolases - hydrolysis (proteases, lipases, phosphatases)
- Lyases - add/remove groups without hydrolysis (decarboxylases)
- Isomerases - structural rearrangements (mutases, epimerases)
- Ligases (Synthetases) - join molecules + ATP (amino acyl-tRNA synthetase)
Mnemonic: "OTHLI L" = "RADHIKA ONLY THINKS HAVING LOVELY INTELLIGENT LOOKS"
= Oxido, Transfer, Hydro, Lyase, Isomerase, Ligase
ISOENZYMES (Short Note)
- Same function, different structure/charge
- Examples: LDH (5 isoforms), CK (3 isoforms), ALP, Amylase
| Isoenzyme | Tissue | Clinical Use |
|---|
| LDH-1 (H₄) | Heart, RBC | ↑ in MI, hemolysis |
| LDH-5 (M₄) | Liver, muscle | ↑ in liver disease |
| CK-MB | Heart | AMI marker (peaks 24h) |
| CK-MM | Skeletal muscle | Rhabdomyolysis |
| CK-BB | Brain | Not clinically useful |
| ALP | Bone, liver, placenta | ↑ in Paget's, cholestasis |
ENZYME INHIBITION
Competitive vs Non-Competitive (Most asked!)
| Feature | Competitive | Non-Competitive |
|---|
| Binds | Active site | Allosteric site |
| Substrate can overcome? | YES (increase [S]) | NO |
| Vmax | UNCHANGED | DECREASED |
| Km | INCREASED | UNCHANGED |
| Lineweaver-Burk | Lines intersect Y-axis | Lines intersect X-axis |
| Example | Methotrexate/DHFR, Statins/HMG-CoA reductase | Cyanide/Cytochrome oxidase |
Mnemonic: "SHUBHAM COMPETES with his Km" = Competitive → Km changes, Vmax same
"NAMANYA is Non-competitive, Never changes Km" = Non-competitive → Km same, Vmax decreases
DIABETIC KETOACIDOSIS - Clinical Summary
PRECIPITANTS: Infection (most common), Omission of insulin, New DM presentation
PATHOPHYSIOLOGY:
No insulin → ↑ Glucagon
↓
↑ Glycogenolysis + ↑ Gluconeogenesis → HYPERGLYCEMIA
↑ Lipolysis → FFA to liver → ↑ Beta oxidation → ↑ Acetyl-CoA
↓
Overwhelmed TCA cycle → HMG-CoA pathway → KETONE BODIES
↓
Metabolic acidosis (pH <7.3, HCO₃ <15)
CLINICAL: Polyuria, polydipsia, vomiting, Kussmaul breathing,
Fruity breath (acetone), Abdominal pain
LABS: Glucose >250, pH <7.3, Bicarbonate <15, Anion gap ↑,
Ketonuria, Ketonemia
TREATMENT: IV fluids → Insulin → KCl replacement
(K⁺ falls further with insulin → MUST replace!)
Mnemonic: "RADHIKA's DKA FIKA HAI" (Hindi: fika = pale/unwell)
- Fluids first
- Insulin (after K >3.5)
- K-replacement (always!)
- Acidosis correction (bicarbonate only if pH <6.9)
GLYCOLYSIS KEY POINTS (LAQ Summary)
GLUCOSE (6C)
↓ Hexokinase/Glucokinase [Step 1] - irreversible, -1 ATP
↓ Phosphoglucoisomerase
↓ PFK-1 [Step 3] - RATE-LIMITING - irreversible, -1 ATP
↓ Aldolase
↓ Triose phosphate isomerase
2× Glyceraldehyde-3-P
↓ GAPDH (NAD+ → NADH)
↓ Phosphoglycerate kinase (+2 ATP each)
↓ Phosphoglycerate mutase
↓ Enolase
↓ Pyruvate kinase [irreversible, +2 ATP each]
2× PYRUVATE
NET: 2 ATP, 2 NADH, 2 Pyruvate
3 Irreversible steps (bypass in gluconeogenesis):
- Hexokinase/Glucokinase → bypassed by Glucose-6-phosphatase
- PFK-1 → bypassed by Fructose-1,6-bisphosphatase
- Pyruvate Kinase → bypassed by PEPCK + Pyruvate carboxylase
Mnemonic: "NAMANYA HPP" = Hexokinase, PFK-1, Pyruvate kinase = 3 irreversible steps
RAPOPORT-LUEBERING CYCLE & 2,3-BPG
- In RBC only: 1,3-BPG → 2,3-BPG (bypasses ATP generation)
- Function of 2,3-BPG: Binds to deoxyhemoglobin → decreases O₂ affinity → RIGHT SHIFT of O₂ dissociation curve → more O₂ delivery to tissues
- Increased in: High altitude, anemia, chronic hypoxia
- Decreased in: Stored blood (causes decreased O₂ delivery)
Mnemonic: "MANIK breathes at altitude, needs more 2,3-BPG"
G6PD DEFICIENCY (Short Clinical)
- X-linked recessive (mostly males)
- HMP shunt blocked → no NADPH → no reduced glutathione → RBC vulnerable to oxidative stress
- Triggers: Primaquine, dapsone, fava beans, infection
- Clinical: Episodic hemolytic anemia, Heinz bodies, bite cells
- Mnemonic: "SHUBHAM eats FAVA, gets FAVA crisis" = favism
HMP SHUNT (Pentose Phosphate Pathway) - Short Note
- Occurs in cytoplasm
- Oxidative phase: Glucose-6-P → Ribulose-5-P + 2 NADPH + CO₂ (G6PD is rate-limiting)
- Non-oxidative phase: Interconversions → Ribose-5-P (for nucleotides)
- Products: NADPH (antioxidant, FA synthesis) + Ribose-5-P (nucleotides)
- Active in: Liver, adrenal cortex, RBC, mammary gland, gonads (steroidogenesis needs NADPH)
PHOSPHOLIPIDS (Short)
- Glycerophospholipids: Lecithin (PC), Cephalin (PE), Phosphatidylserine, Phosphatidylinositol
- Lecithin (PC): Major lung surfactant (L/S ratio >2 = fetal lung maturity)
- Sphingomyelin: Sphingosine + phosphocholine (myelin sheath)
- Plasmalogen: Ether-linked FA, important in myelin and heart
LIPOPROTEINS (Quick Table)
| Lipoprotein | Made in | Carries | Apo | Clinical |
|---|
| Chylomicron | Intestine | Dietary TG | B-48, A, C, E | Pancreatitis if ↑ |
| VLDL | Liver | Endogenous TG | B-100, C, E | Precursor to LDL |
| IDL | Plasma | TG+Chol | B-100, E | Intermediate |
| LDL | Plasma | Cholesterol | B-100 | "Bad" cholesterol |
| HDL | Liver/intestine | Reverse transport | A-I, A-II | "Good" cholesterol |
Mnemonic: "DIVYA COMES VERY LATE" = Chylomicron (C), VLDL (V), IDL, LDL (L) = increasing density, decreasing TG
UREA CYCLE DISORDERS - Quick Differentials
| Disorder | Defect | Orotic Acid | Treatment Hint |
|---|
| CPS-I def | CPS-I | ↓ (absent) | N-carbamylglutamate |
| OTC def (most common) | OTC | ↑ | Na benzoate + Na phenylacetate |
| Citrullinemia | AS synthetase | ↑ | Arginine restriction |
| Argininosuccinic aciduria | AS lyase | ↑ | Arginine supplementation |
| Arginase def | Arginase | ↑ | Low protein diet |
PHENYLKETONURIA (PKU) - Clinical Short
- Defect: Phenylalanine hydroxylase (PAH) deficiency → Phe → cannot convert to Tyrosine
- Accumulates: Phenylpyruvate, phenylacetate, phenyllactate
- Clinical: Intellectual disability, seizures, fair skin, musty odor, eczema
- Screen: Guthrie test (neonatal screening)
- Treatment: Phenylalanine-restricted diet; Sapropterin (BH4 cofactor) for responsive forms
- Mnemonic: "MANIK PKU = Musty + Kehta nahi (no tyrosine synthesis)"
GALACTOSEMIA - Clinical Short
- Classic: Galactose-1-P uridyltransferase deficiency
- Accumulates: Galactose-1-phosphate (toxic to liver, brain, lens)
- Clinical: Jaundice, liver damage, cataracts, E. coli sepsis in neonates, intellectual disability
- Treatment: Eliminate lactose and galactose from diet
- Mnemonic: "DIVYA got GALACT + Cataracts + E. coli"
LESCH-NYHAN SYNDROME
- Defect: HGPRT (Hypoxanthine-Guanine Phosphoribosyl Transferase) - purine salvage pathway
- X-linked recessive
- Accumulates: Uric acid
- Clinical: Gout + Self-mutilation (lip/finger biting) + Intellectual disability + Choreoathetosis
- Mnemonic: "NAMANYA bites herself" = Lesch-Nyhan = self-injurious behavior
SUMMARY SCORING SHEET - HIGH YIELD KEY WORDS
Use these words in your answers to impress the checker:
Regulation of Blood Glucose:
- "cAMP-dependent protein kinase cascade"
- "Glucose-6-phosphatase - hepatic glucose export"
- "F-2,6-bisphosphate - key allosteric regulator"
- "Counter-regulatory hormones"
- "AMPK - cellular energy sensor"
Beta Oxidation:
- "CPT-I - carnitine shuttle - rate-limiting step"
- "Malonyl-CoA inhibits CPT-I"
- "FADH₂ and NADH generated per cycle"
- "Peroxisomal vs mitochondrial oxidation"
- "Very long chain fatty acids - peroxisomal oxidation"
Ammonia/Urea Cycle:
- "Glutamine - primary nitrogen transport molecule"
- "Alanine-glucose cycle"
- "N-acetylglutamate - obligatory activator of CPS-I"
- "OTC deficiency - X-linked - orotic acid elevated"
- "4 ATP equivalents consumed per urea molecule"
- "Arginase present in liver only"
Ketone Bodies:
- "HMG-CoA synthase - rate-limiting step"
- "SCOT absent in liver - cannot utilize ketone bodies"
- "Ketonemia, ketonuria, Kussmaul breathing"
- "β-hydroxybutyrate:acetoacetate ratio elevated in DKA"
Sources: Lippincott's Illustrated Reviews in Biochemistry 8th ed; Basic Medical Biochemistry: A Clinical Approach 6th ed; Sleisenger & Fordtran's Gastrointestinal & Liver Disease; Tietz Textbook of Laboratory Medicine 7th ed
Last-minute tip (RADHIKA, NAMANYA, DIVYA, SHUBHAM, MANIK - ek team bana lo!):
Each person owns one topic:
- RADHIKA = Regulation of glucose
- NAMANYA = kNockout enzymes (enzyme inhibition)
- DIVYA = DKA + ketone bodies
- SHUBHAM = Shunts (HMP, urea cycle)
- MANIK = Metabolism of amino acids (PKU, Homocystinuria)